Sparkling Water Offers Minimal Weight Loss Benefits, Study Reveals Written By Anshika Mishra20 April 2026 8:30 AM ISTCan your fizzy water habit actually help you lose weight-or is it just bubbles and hype? A new analysis published in BMJ Nutrition Prevention &...
GLP-1RAs Expanding Clinical Scope Beyond Glycemic Control: Review Suggests Written By Aashi verma11 April 2026 10:00 AM ISTGlucagon-like peptide-1 receptor agonists (GLP-1RAs) have remarkably transitioned from specialized diabetes treatments to versatile therapeutic agents...
Metformin: Anchoring Potential in GLP-1 RA Care Journey Written By Dr Manjunath Havalappa Dodamani8 April 2026 12:59 PM ISTIndia is confronting a metabolic health crisis of significant magnitude, 254 million adults with generalised obesity, 351 million with abdominal...
Pfizer's GLP-1 Drug Xianweiying Wins China Approval for Long-Term Weight Management Written By sheeba farhat8 March 2026 11:30 AM ISTShanghai: China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said...
NICE 2026 Updates Type 2 Diabetes Care: Cardiovascular Focus, Early SGLT-2 Use Takes Forefront Written By Aditi Dhingra2 March 2026 12:30 PM ISTThe most recent version of NG28, the National Institute for Health and Care Excellence's (NICE) guidelines for managing type 2 diabetes in adults, has...
Natco Pharma Gets Court Nod to Make, Export Semaglutide for Diabetes and Obesity Markets Written By Susmita Roy10 Feb 2026 7:32 PM ISTNew Delhi: Natco Pharma has secured regulatory clearance from the High Court to manufacture semaglutide and export the drug to select international...
Emcure Beats 9 Rivals to Secure Second Semaglutide Brand from Novo Nordisk for India Written By Parthika Patel5 Feb 2026 10:31 PM ISTNew Delhi: Emcure Pharmaceuticals has secured exclusive rights to market a second brand of semaglutide in India through a partnership with Novo...
SURPASS-2: Superior HbA1c and Weight Reduction With Tirzepatide vs. Semaglutide Written By Deeksha Bhandari29 Jan 2026 11:00 AM ISTThe SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already...
Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market Written By sheeba farhat5 Jan 2026 6:19 PM ISTThe Wegovy pill ​could attract new consumers as Novo looks to revive ​its fortunes after profit warnings and sliding shares in 2025.
Explainer Video: Acknowledge- Assisting Patients Through Challenges in Their Diabetes Care Journey Written By MDTV Bureau22 Nov 2025 12:01 PM IST Weight management is an important but challenging part of type 2 diabetes care, especially for people with overweight or obesity. Even...
Explainer video: Assess- Evaluating Patient Readiness for Diabetes- Management Strategies Written By MDTV Bureau31 Oct 2025 12:01 PM ISTDiscussing weight with people living with type 2 diabetes can be difficult, but it is vital to improving care. Many patients with overweight or...
Tirzepatide proves to be more effective than semaglutide- Results of Surmount 5 Trial Written By Professor Carel W. le Roux3 Oct 2025 12:09 PM ISTSURMOUNT-5 was a 72-week, Phase 3b, multicenter, randomized, open-label, comparator-controlled study that evaluated the efficacy and safety of...
